DAWN MASON: Open Payments
NPI 1033685169 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,412 in 40 payments from 8 companies in 2025. Trend: 2023 $5,602 · 2024 $8,044 · 2025 $7,412
Speaker / faculty: $6,250Food & beverage: $697Travel & lodging: $465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $6,974 |
| Neurocrine BioSciences, Inc. | 4 | $192 |
| Novo Nordisk Inc | 1 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| LivaNova USA, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, REXULTI, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, QULIPTA, Auvelity.
Industry payments across WA — which companies pay providers there.
